About
Titles
Associate Professor of Medicine (Cardiovascular Medicine)
Chief, Heart Failure Program
Biography
I am the Chief of Heart Failure at Yale Cardiology. I focus on the care of patients with end stage heart failure, left ventricular assist devices, and heart transplants. My Internal Medicine training was at Brigham and Women's Hospital, Harvard Medical School in Boston. During that time, I received an MPH from Harvard School of Public Health. I did my fellowship in Cardiovascular Medicine and Advanced Heart Failure at Duke University Medical Center along with a two year research fellowship at DCRI. My research interest is in using data to improve the care of heart failure patients. I partner with several investigators at Yale to run pragmatic clinical trials across the health system that are aimed at answering foundational questions about the practice of heart failure.
Appointments
Cardiovascular Medicine
Associate Professor on TermPrimary
Other Departments & Organizations
- Cardiovascular Medicine
- Center for Biomedical Data Science
- Clinical and Translational Research Accelerator (CTRA)
- Heart Failure Program
- Heart Transplant and Left Ventricular Assist Device Program
- Internal Medicine
- Yale Medicine
Education & Training
- Advanced Heart Failure Fellow
- Duke University Medical Center (2015)
- Fellow
- Duke University Medical Center (2014)
- Research Fellow
- Duke Clinical Research Institute (2014)
- MPH
- Harvard School of Public Health (2010)
- Intern and Resident
- Brigham and Women's Hospital (2010)
- MD
- SUNY at Stony Brook School of Medicine (2006)
- BA
- New York University, Mathematics and Biology (2001)
Research
Publications
2025
Days Alive Out of Hospital for Patients with Left Ventricular Dysfunction From the STICH Trial
Faridi K, Huang H, Parise H, Ahmad T, Mori M, Chung M, Yeh R, Petrie M, Panza J, Rouleau J, Dabrowski R, Velazquez E. Days Alive Out of Hospital for Patients with Left Ventricular Dysfunction From the STICH Trial. JACC Heart Failure 2025, 13: 867-869. PMID: 40335237, DOI: 10.1016/j.jchf.2025.02.019.Peer-Reviewed Original ResearchCoronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy
Reinhardt S, Huang H, Parise H, Ahmad T, Velazquez E, Faridi K. Coronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy. American Heart Journal Plus Cardiology Research And Practice 2025, 54: 100538. PMID: 40485767, PMCID: PMC12142554, DOI: 10.1016/j.ahjo.2025.100538.Peer-Reviewed Original ResearchCoronary artery bypass graftingAll-cause mortalityIschemic cardiomyopathyMean survival timeMedical therapyRestricted mean survival timeClinical trialsEndpoint of all-cause mortalityInternational multicenter randomized clinical trialSurvival timeCoronary artery bypass surgeryOptimal medical therapyMulticenter randomized clinical trialBenefit of coronary artery bypass graftingEffect of coronary artery bypass graftingIschemic heart failureArtery bypass surgeryCox proportional hazards modelsArtery bypass graftingRandomized clinical trialsProportional hazards modelSurgical treatmentBypass surgeryHeart failureBypass graftingMEDICARE AND MEDICAID UTILIZATION AND ASSOCIATED SPENDING ON SGLT2 INHIBITORS AND GLP1 RECEPTOR AGONISTS
Fernandes W, Bansal K, Fernandes B, rahman I, Riello R, Faridi K, Ahmad T, Desai N. MEDICARE AND MEDICAID UTILIZATION AND ASSOCIATED SPENDING ON SGLT2 INHIBITORS AND GLP1 RECEPTOR AGONISTS. Journal Of The American College Of Cardiology 2025, 85: 544. DOI: 10.1016/s0735-1097(25)01028-9.Peer-Reviewed Original ResearchElectronic health record nudges to optimize guideline-directed medical therapy for heart failure
Fuery M, Clark K, Sikand N, Tabtabai S, Sen S, Wilson F, Desai N, Ahmad T, Samsky M. Electronic health record nudges to optimize guideline-directed medical therapy for heart failure. Heart Failure Reviews 2025, 30: 771-776. PMID: 40106122, DOI: 10.1007/s10741-025-10503-4.Peer-Reviewed Original ResearchConceptsElectronic health recordsClinical decision supportGuideline-directed medical therapyPotential of electronic health recordsElectronic health record systemsDiverse healthcare settingsGDMT adherenceCare qualityClinician workflowHealth recordsAlert contentHF careHealthcare settingsPatient careInformed treatment decisionsTargeted alertingQuality gapEnhanced usabilityImprove heart failureHeart failureDecision supportReal-timeCareTreatment decisionsAlerting strategyMedicare Coverage and Patient Out-of-Pocket Costs for Mavacamten
Bansal K, Chien C, Masri A, Riello R, Ahmad T, Desai N, Dani S. Medicare Coverage and Patient Out-of-Pocket Costs for Mavacamten. Circulation Cardiovascular Quality And Outcomes 2025, 18: e011331. PMID: 39817331, DOI: 10.1161/circoutcomes.124.011331.Peer-Reviewed Original ResearchMechanical Circulatory Support in Patients Without Cardiogenic Shock Undergoing Percutaneous Coronary Intervention
Miller P, Gordon A, Liu Y, Ahmad T, Bromfield S, Girotra S, Davila C, Crawford G, Whitney J, Desai N. Mechanical Circulatory Support in Patients Without Cardiogenic Shock Undergoing Percutaneous Coronary Intervention. Journal Of The American Heart Association 2025, 14: e037424. PMID: 39791394, PMCID: PMC12054512, DOI: 10.1161/jaha.124.037424.Peer-Reviewed Original ResearchConceptsMicroaxial left ventricular assist deviceIntra-aortic balloon pump usePercutaneous coronary interventionIntra-aortic balloon pumpBalloon pump useCardiogenic shockLeft ventricular assist deviceTotal health care costsIndex admissionBalloon pumpIncident dialysisHealth care costsCoronary interventionAssociated with lower mortalityPump useLVAD useHigh-risk percutaneous coronary interventionAssociated with higher costsInverse probability treatmentCare costsMechanical circulatory supportInsured populationSecondary outcomesPrimary outcomeRetrospective study
2024
Automated Identification of Heart Failure With Reduced Ejection Fraction Using Deep Learning-Based Natural Language Processing
Nargesi A, Adejumo P, Dhingra L, Rosand B, Hengartner A, Coppi A, Benigeri S, Sen S, Ahmad T, Nadkarni G, Lin Z, Ahmad F, Krumholz H, Khera R. Automated Identification of Heart Failure With Reduced Ejection Fraction Using Deep Learning-Based Natural Language Processing. JACC Heart Failure 2024, 13: 75-87. PMID: 39453355, DOI: 10.1016/j.jchf.2024.08.012.Peer-Reviewed Original ResearchReduced ejection fractionEjection fractionHeart failureLeft ventricular ejection fractionVentricular ejection fractionYale-New Haven HospitalIdentification of patientsCommunity hospitalIdentification of heart failureLanguage modelNorthwestern MedicineMeasure care qualityQuality of careNew Haven HospitalDeep learning-based natural language processingHFrEFGuideline-directed careDeep learning language modelsMIMIC-IIIDetect HFrEFNatural language processingReclassification improvementHospital dischargePatientsCare qualityImpact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock
Bansal K, Gupta M, Garg M, Patel N, Truesdell A, Babar Basir M, Rab S, Ahmad T, Kapur N, Desai N, Vallabhajosyula S. Impact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock. JACC Heart Failure 2024, 12: 2087-2097. PMID: 39243243, DOI: 10.1016/j.jchf.2024.07.014.Peer-Reviewed Original ResearchPercutaneous coronary interventionCardiogenic shockAcute myocardial infarctionAnnual PCI volumesHeart failureAll-causeHigh-volume PCI centersHigh-volume centersAMI-CSNationwide Readmissions DatabaseMedian annual PCI volumesVolume-outcome relationshipAMI-CS admissionsHospital PCI volumePercutaneous coronary intervention volumeVolume centersOrgan dysfunctionPCI centerMultivariable adjustmentHF readmissionSupportive therapyHighest quartilesQ1 hospitalsNoncardiac readmissionComorbidity burdenContemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis
Bansal K, Majmundar V, Young G, Riello R, Faridi K, Ahmad T, Desai N. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis. JACC Heart Failure 2024, 12: 1791-1793. PMID: 39115517, DOI: 10.1016/j.jchf.2024.07.002.Peer-Reviewed Original ResearchIschemic Stroke and Reduced Left Ventricular Ejection Fraction: A Multidisciplinary Approach to Optimize Brain and Cardiac Health
McNamara K, Merkler A, Freeman J, Krumholz H, Ahmad T, Sharma R. Ischemic Stroke and Reduced Left Ventricular Ejection Fraction: A Multidisciplinary Approach to Optimize Brain and Cardiac Health. Stroke 2024, 55: 1720-1727. PMID: 38660813, DOI: 10.1161/strokeaha.123.045623.Peer-Reviewed Original ResearchConceptsReduced left ventricular ejection fractionLeft ventricular ejection fractionIschemic strokeVentricular ejection fractionAdverse cardiac outcomesRecurrent acute ischemic strokeAcute ischemic stroke hospitalizationsIschemic stroke hospitalizationsAcute ischemic strokeCardiac healthEjection fractionCardiac outcomesStroke hospitalizationsRisk factorsCare paradigmOptimal brainMultidisciplinary approachHealthBrain
Academic Achievements & Community Involvement
Clinical Care
Overview
Tariq Ahmad, MD, MPH, is a cardiologist who specializes in treating patients with end-stage heart failure and heart transplants. He also cares for patients with cardiomyopathies, which are diseases of the heart muscle, and advanced valvular diseases. “I help take care of patients who have been told that they are out of options. In some ways, it’s like the oncology of cardiology,” Dr. Ahmad says.
Dr. Ahmad traces his love of medicine to his grandfather, a surgeon, who would allow him to follow along on hospital rounds. But his decision to pursue cardiology happened with more serendipity. “In medical school, I read a cardiology textbook that was just beautifully written. It was an outstanding book and I kept reading it and decided I would pursue that specialty,” Dr. Ahmad says.
“For hundreds of years we’ve developed a physical exam around the properties of the heart,” he says. “There’s lots of dimensions to it that are absolutely fascinating.”
Away from his patients’ bedsides, Dr. Ahmad is deeply involved in research that attempts to better understand how heart failure happens. “I’ve investigated blood molecules that can help predict who is going to have more advanced diseases, and who is not. These are called biomarkers, and we are still working to improve them.”
At Yale School of Medicine, Dr. Ahmad is an assistant professor of cardiology.
Clinical Specialties
Fact Sheets
Ventricular Assist Device (VAD)
Learn More on Yale MedicineExtracorporeal Membrane Oxygenation (ECMO)
Learn More on Yale MedicineHeart Transplant
Learn More on Yale MedicineHeart Disease in Women
Learn More on Yale Medicine
Yale Medicine News
News
News
- April 01, 2024
Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions
- September 14, 2023
Electronic Health Record Strategies Can Improve Care of Patients with Heart Failure
- June 06, 2023Source: Medscape
EHR Nudges a Bust for Boosting Guideline-Directed Meds in Acute HF: PROMPT-AHF
- June 01, 2023Source: TCTMD
Boosting GDMT and Improving Outcomes? No Mean Task After AHF
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.